Studies have shown that protein PTP1B, a molecular target for anti-type II diabetes, obesity, and cancer treatment, can regulate the level of protein tyrosine phosphorylation in cells (Chen et al., 2018). The gene discussed is PTPN1; the disease is obesity due to melanocortin 4 receptor deficiency.